Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The campaign highlights a straightforward, achievable approach to health, proving that supporting your wellness doesn’t have to be complicated
Subscribe To Our Newsletter & Stay Updated
